China Molecular Diagnostics In Pharmacogenomics Market Size & Outlook
Related Markets
China molecular diagnostics in pharmacogenomics market highlights
- The China molecular diagnostics in pharmacogenomics market generated a revenue of USD 34.2 million in 2024 and is expected to reach USD 66.3 million by 2033.
- The China market is expected to grow at a CAGR of 7.8% from 2025 to 2033.
- In terms of segment, kits and assays was the largest revenue generating product in 2024.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Molecular diagnostics in pharmacogenomics market data book summary
| Market revenue in 2024 | USD 34.2 million |
| Market revenue in 2033 | USD 66.3 million |
| Growth rate | 7.8% (CAGR from 2025 to 2033) |
| Largest segment | Kits and assays |
| Fastest growing segment | Services |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits and assays, Reagents, Services |
| Key market players worldwide | Roche Diagnostics, Qiagen NV, Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Genomind, OneOme, Myriad Genetics Inc, Invitae Corp, Abbott Molecular |
Other key industry trends
- In terms of revenue, China accounted for 4.9% of the global molecular diagnostics in pharmacogenomics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China molecular diagnostics in pharmacogenomics market is projected to lead the regional market in terms of revenue in 2033.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 55.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Molecular Diagnostics in Pharmacogenomics Market Scope
Molecular Diagnostics in Pharmacogenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Molecular | View profile | 51-100 | Des Plaines, Illinois, United States, North America | https://www.abbottmolecular.com/ |
| OneOme | View profile | 11-50 | Minneapolis, Minnesota, United States, North America | http://oneome.com/ |
| Genomind | View profile | 101-250 | Chalfont, Pennsylvania, United States, North America | http://www.genomind.com |
| Roche Diagnostics | View profile | - | - | - |
| Invitae Corp | View profile | 1700 | 1400 16th Street, San Francisco, CA, United States, 94103 | https://www.invitae.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
China molecular diagnostics in pharmacogenomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics in pharmacogenomics market will help companies and investors design strategic landscapes.
Kits and assays was the largest segment with a revenue share of 50.88% in 2024. Horizon Databook has segmented the China molecular diagnostics in pharmacogenomics market based on kits and assays, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to China molecular diagnostics in pharmacogenomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China molecular diagnostics in pharmacogenomics market databook
-
Our clientele includes a mix of molecular diagnostics in pharmacogenomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China molecular diagnostics in pharmacogenomics market , including forecasts for subscribers. This country databook contains high-level insights into China molecular diagnostics in pharmacogenomics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
China molecular diagnostics in pharmacogenomics market size, by product, 2021-2033 (US$M)
China Molecular Diagnostics in Pharmacogenomics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
